Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 566 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Vaginal Diseases Clear all

Conditions: Other Disorders of Bone Development and Growth
Interventions: Combined Oral Contraceptive (COC), Contraceptive Vaginal Ring (CVR); Drug
Lead sponsor: Penn State University; Other
Eligibility: 18 Years to 25 Years · Female only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Atrophic Vaginitis, Menopause, Recurrent Urinary Tract Infections
Interventions: Conjugated equine estrogen topical cream, Apricot kernel oil; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older · Female only
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Chlamydial Infection, Gonococcal Infection
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 16 Years to 75 Years · Female only
Enrollment: 3,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Infertility
Interventions: Endometrin, Progesterone in Oil; Drug
Lead sponsor: Fertility Centers of Illinois; Other
Eligibility: 21 Years to 49 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stress Urinary Incontinence
Interventions: pessary, Absorbent pad; Device
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: Infertility, Pregnancy
Interventions: Crinone vaginal progesterone gel, Placebo vaginal gel; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Vaginal Dysbiosis, Vaginal Disease, Molecular-bacterial Vaginosis
Interventions: Probiotic Group, Placebo Group; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Vaginal Cancer
Interventions: Lymphoscintigraphy; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Vaginal Discharge, Postcoital Vaginal Changes
Interventions: Livi Postcoital Tampon Device; Device
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Mountain Lakes, New Jersey

Conditions: Vaginal Infection
Interventions: Terconazole, Placebo; Drug
Lead sponsor: Curatek Pharmaceuticals, LLC; Industry
Eligibility: 12 Years and older · Female only
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 41
States / cities: Birmingham, Alabama • Chandler, Arizona • Scottsdale, Arizona + 35 more

Conditions: Surgery, Knowledge, Attitudes, Practice, Prolapse, Vaginal, Urinary Incontinence
Interventions: Preoperative support person present, Patient Present Only; Other
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Atrophic Vaginitis
Interventions: Estradiol Vaginal Cream, 0.01%, Estrace® 0.01% cream, Placebo Vaginal Cream; Drug
Lead sponsor: Mylan Pharmaceuticals Inc; Industry
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 366 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 21
States / cities: Tucson, Arizona • Los Angeles, California • Sacramento, California + 16 more

Conditions: Bacterial Vaginosis
Interventions: SYM-1219; Drug
Lead sponsor: Symbiomix Therapeutics; Industry
Eligibility: 12 Years and older · Female only
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 40
States / cities: Birmingham, Alabama • Phoenix, Arizona • Jonesboro, Arkansas + 34 more

Conditions: Obesity
Interventions: Transvaginal NOTES sleeve gastrectomy; Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 75 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2018
U.S. locations: 1
States / cities: San Diego, California

Conditions: Endometrial Cancer
Interventions: Bouquet Speculum; Device
Lead sponsor: Rocky Vista University, LLC; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Ovarian Cancer, Genetic Predisposition to Disease
Interventions: Self-Administered Sample Collection; Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 30 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)
Interventions: 7-0940; Device
Lead sponsor: Stratpharma AG; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 14
States / cities: Birmingham, Alabama • Burbank, California • Laguna Hills, California + 11 more

Conditions: Female Sexual Dysfunction, Spinal Cord Injuries
Interventions: Transcutaneous electrical nerve stimulation - Tibial Nerve, Transcutaneous electrical nerve stimulation - Genital Nerve; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chorioamnionitis
Interventions: saline, ampicillin gentamicin, ampicillin gentamicin clindamycin; Drug
Lead sponsor: United States Naval Medical Center, Portsmouth; Federal
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Portsmouth, Virginia

Conditions: Stress Urinary Incontinence, Prolapse
Interventions: Continued Pessary Use; Device
Lead sponsor: Loyola University; Other
Eligibility: 51 Years and older · Female only
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Appendix Adenocarcinoma, Human Papillomavirus-Related Anal Squamous Cell Carcinoma, Human Papillomavirus-Related Cervical Squamous Cell Carcinoma, Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis, Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma, Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Tumor, Recurrent Merkel Cell Carcinoma, Recurrent Nasopharynx Carcinoma, Recurrent Peritoneal Malignant Mesothelioma, Recurrent Pleural Malignant Mesothelioma, Stage III Merkel Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Carcinoma AJCC v7, Stage III Pleural Malignant Mesothelioma AJCC v7, Stage IV Merkel Cell Carcinoma AJCC v7, Stage IV Nasopharyngeal Carcinoma AJCC v7, Stage IV Pleural Malignant Mesothelioma AJCC v7, Stage IVA Nasopharyngeal Carcinoma AJCC v7, Stage IVB Nasopharyngeal Carcinoma AJCC v7, Stage IVC Nasopharyngeal Carcinoma AJCC v7, Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
Interventions: Atezolizumab, Bevacizumab, Laboratory Biomarker Analysis, Pharmacological Study; Drug · Biological · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Sexually Transmitted Diseases, Gonorrhea, Chlamydia
Interventions: EVO100, Placebo; Drug
Lead sponsor: Evofem Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,892 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 98
States / cities: Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 71 more

Conditions: Pelvic Organ Prolapse, Urinary Incontinence
Interventions: Not listed
Lead sponsor: Atlantic Health System; Other
Eligibility: 21 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Vaginal Prolapse, Uterine Prolapse, Cystocele, Pelvic Organ Prolapse
Interventions: synthetic polypropylene mesh; Device
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 21 Years and older · Female only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Assessing the Impact of Contraceptives on Bone Health Using 41Ca

Vaginal and Urinary Microbiome Trial

Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing

Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs

A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence

Sexual Absorption of Vaginal Progesterone

Feasibility of an Oral Intervention for Sexual Health in Transgender Men

Lymphoscintigraphy in Patients With Vaginal Cancer

In-Clinic Assessment of Vaginal Mucosal Safety Following Repetitive Use of the Livi Device

Multi-Center Study of New Medications to Treat Vaginal Infections

What is the Impact of the Presence of a Support Person on Informed Consent

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

Transvaginal NOTES Sleeve Gastrectomy

The Use of a Novel Vaginal Speculum for Endometrial Biopsies

Healthy Volunteers Study

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Effect of Peripheral Neuromodulation on Vaginal Blood Flow

Treatment of Chorioamnionitis After Delivery

Host Response to Pessaries in Microbial Communities of the Postmenopausal Vagina

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review

Efficacy Study of Vaginal Mesh for Anterior Prolapse